AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glycoprize MV 2 Tablet SR

Prescription Icon
Prescription Required

Marketer

Mnicro Labs Pvt. Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glycoprize MV 2 Tablet SR

Diabetic patients using the extended-release formulation, Diabeta-Comb 2 SR, should be aware that this anti-diabetic medication is a dual-action formulation for managing type 2 diabetes in adults. Its purpose is to maintain healthy blood glucose control. Diabeta-Comb 2 SR tablets must be ingested with food, consistently at the same time daily for optimal efficacy. Dosage adjustments are determined by your physician, based on regular blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications such as kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication is only one component of a comprehensive diabetes management plan that necessitates a balanced diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect. Learn to recognize symptoms like tremors, sweating, dizziness, and headaches, and know how to treat them promptly. Regular meals and carrying readily available glucose sources, such as fruit juice or sweets, are essential preventative measures. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, gastrointestinal upset (nausea, diarrhea, abdominal pain), headaches, edema, blurred vision, increased risk of fractures, upper respiratory infections, and weight gain. This medicine is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Consult your doctor before using this medication if you are pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are vital during treatment.

Uses of Glycoprize MV 2 Tablet SR

Managing type 2 diabetes

Major Benefits of Glycoprize MV 2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glycoprize MV 2 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication on an empty stomach.

Common Side effects of Glycoprize MV 2 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glycoprize MV 2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glycoprize MV 2 Tablet SR whole; do not crush, chew, or break it. Administer on an empty stomach.

How Glycoprize MV 2 Tablet SR works:

Glycoprize MV 2 extended-release tablets contain a triple-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Glycoprize MV 2 Tablet SR is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glycoprize MV 2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Glycoprize MV 2 Tablet may pose a risk to breastfeeding infants. Available human data indicates potential transfer to breast milk, potentially causing harm to the nursing child.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

Patients with kidney impairment should likely avoid Glycoprize MV 2 Tablet SR, as its use may be unsafe. Those with severe kidney disease should definitely not use this medication. A physician's consultation is advised.

LiverLiverCAUTION

Individuals with liver impairment should use Glycoprize MV 2 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Glycoprize MV 2 Tablet SR is typically initiated at a low dose; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glycoprize MV 2 Tablet SR :

Should you forget to take a Glycoprize MV 2 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glycoprize MV 2 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glycoprize MV 2 Tablet SR

Glycoprize MV 2 Tablet SR combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus in adults. This triple therapy improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers postprandial glucose. This combination is unsuitable for type 1 diabetes.
Glycoprize MV 2 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste perception, gas, stomach pain, headache, rash, and respiratory infections.
Glycoprize MV 2 Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate-to-severe kidney disease, inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Glycoprize MV 2 Tablet SR and alcohol is unsafe. This combination may cause dangerously low blood sugar and increase the risk of lactic acidosis.
Glycoprize MV 2 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Glycoprize MV 2 Tablet SR
234
MRP 285
17% off